A prospective cohort study of treatment efficacy of biologics for severe asthma in children and young adults for prevention of airway remodeling
Not Applicable
Recruiting
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000050429
- Lead Sponsor
- ational Mie Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Those who have already started and are stable on the use of the following biologics.(omalizumab, mepolizumab, venlalizumab, dupilumab, tezepelumab) 2) Those who have requested to opt out of this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in respiratory function before and after administration of each biologic
- Secondary Outcome Measures
Name Time Method 1. Changes in Clinical Symptoms Before and After Introduction of Biological Agents 2. Biomarker changes before and after introduction of biologics